Literature DB >> 9433861

Biotinidase deficiency: two cases of very early presentation.

A Haagerup1, J B Andersen, S Blichfeldt, M F Christensen.   

Abstract

Two infants with early presentation of biotinidase deficiency (age 3 weeks and 2 weeks) are described. On admission, both children had severe neurological symptoms. In the first patient, magnetic resonance imaging (MRI) of the brain showed frontal and temporal atrophy, and in the second patient, CT of the brain showed diffuse periventricular hypodensities, particularly in the frontal region. Oral treatment with biotin (15mg and 10mg per day respectively) made all symptoms disappear within a few weeks. On follow-up 13 and 16 months later, both children were still asymptomatic on this treatment. Their psychomotor development was normal. MRI and CT of the brain had normalized. Later, a moderate hearing loss was detected in the first patient. In biotinidase deficiency, early diagnosis and treatment with oral biotin are essential in order to prevent irreversible damage to the central nervous system and early death from metabolic acidosis. Neonatal screening for biotinidase deficiency would fulfil this goal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9433861     DOI: 10.1111/j.1469-8749.1997.tb07553.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  2 in total

1.  Biotinidase deficiency: the importance of adequate follow-up for an inconclusive newborn screening result.

Authors:  Trevor L Hoffman; Erin M Simon; Can Ficicioglu
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.860

2.  Biotinidase Deficiency in Newborns as Respiratory Distress and Tachypnea: A Case Report.

Authors:  Shahin Koohmanaee; Marjaneh Zarkesh; Manijeh Tabrizi; Afagh Hassanzadeh Rad; Siamak Divshali; Setila Dalili
Journal:  Iran J Child Neurol       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.